ArticleProceedings of the National Academy of Sciences of the United States of America2022

TGFB2-AS1 inhibits triple-negative breast cancer progression via interaction with SMARCA4 and regulating its targets

Cixiang Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.